← All stories
Markets
Where Did Ananda Pharma (LSE:ANA) Take Its Cannabidiol Programme After Leaving The Market?
Highlights Shareholders approved withdrawal from the growth market by a wide margin. The company re-registered as a private company after dealings ceased. Its lead cannabidiol formulation targets pain indications rather than epilepsy. A Can…
Covered by 1 outlet
All coverage · 1 article